| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 133, 2861-2870, Copyright © 1993 by Endocrine Society
ARTICLES |
TB Usdin, E Mezey, DC Button, MJ Brownstein and TI Bonner
Laboratory of Cell Biology, National Institute of Mental Health, Bethesda, Maryland 20892.
Gastric inhibitory polypeptide (GIP), or glucose-dependent insulinotropic peptide, is released from endocrine cells in the small intestine after meals. It is involved in several facets of the anabolic response and is thought to be particularly important in stimulating insulin secretion. We have cloned, functionally expressed, and mapped the distribution of the receptor for GIP. It is a member of the secretin-vasoactive intestinal polypeptide family of G-protein-coupled receptors. When expressed in tissue culture cells, it stimulates cAMP production (EC50 0.3 nM) and also increases intracellular calcium accumulation. GIP receptor mRNA is present in the pancreas as well as the gut, adipose tissue, heart, pituitary, and inner layers of the adrenal cortex, whereas it is not found in kidney, spleen, or liver. It is also expressed in several brain regions, including the cerebral cortex, hippocampus, and olfactory bulb. These results suggest that GIP may have previously undescribed actions. GIP receptor localization in the adrenal cortex suggests that it may have effects on glucocorticoid metabolism. Neither GIP nor its effects have been described in the central nervous system, and mRNA for the known peptide ligand for the receptor cannot be detected in the brain by in situ hybridization or polymerase chain reaction. This suggests that a novel peptide may be present in the brain.
This article has been cited by other articles:
![]() |
N. Harada, Y. Yamada, K. Tsukiyama, C. Yamada, Y. Nakamura, E. Mukai, A. Hamasaki, X. Liu, K. Toyoda, Y. Seino, et al. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic {beta}-cells in obese mice Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E61 - E68. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. McClean, N. Irwin, R. S. Cassidy, J. J. Holst, V. A. Gault, and P. R. Flatt GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1746 - E1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Meier, J. J. Holst, W. E. Schmidt, and M. A. Nauck Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E849 - E856. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Parthier, M. Kleinschmidt, P. Neumann, R. Rudolph, S. Manhart, D. Schlenzig, J. Fanghanel, J.-U. Rahfeld, H.-U. Demuth, and M. T. Stubbs Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor PNAS, August 28, 2007; 104(35): 13942 - 13947. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Kim, C. Nian, and C. H. S. McIntosh Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes: A ROLE FOR A PROTEIN KINASE B, LKB1, AND AMP-ACTIVATED PROTEIN KINASE CASCADE J. Biol. Chem., March 23, 2007; 282(12): 8557 - 8567. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamada, K. Miyawaki, K. Tsukiyama, N. Harada, C. Yamada, and Y. Seino Pancreatic and Extrapancreatic Effects of Gastric Inhibitory Polypeptide Diabetes, December 1, 2006; 55(Supplement_2): S86 - S91. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Boylan, L. I. Jepeal, and M. M. Wolfe Sp1/Sp3 binding is associated with cell-specific expression of the glucose-dependent insulinotropic polypeptide receptor gene Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1287 - E1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Mazzuco, O. Chabre, N. Sturm, J.-J. Feige, and M. Thomas Ectopic Expression of the Gastric Inhibitory Polypeptide Receptor Gene Is a Sufficient Genetic Event to Induce Benign Adrenocortical Tumor in a Xenotransplantation Model Endocrinology, February 1, 2006; 147(2): 782 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Baldacchino, S. Oble, P.-O. Decarie, I. Bourdeau, P. Hamet, J. Tremblay, and A. Lacroix The Sp transcription factors are involved in the cellular expression of the human glucose-dependent insulinotropic polypeptide receptor gene and overexpressed in adrenals of patients with Cushing's syndrome J. Mol. Endocrinol., August 1, 2005; 35(1): 61 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Gault, N. Irwin, B. D. Green, J. T. McCluskey, B. Greer, C. J. Bailey, P. Harriott, F. P.M. O'Harte, and P. R. Flatt Chemical Ablation of Gastric Inhibitory Polypeptide Receptor Action by Daily (Pro3)GIP Administration Improves Glucose Tolerance and Ameliorates Insulin Resistance and Abnormalities of Islet Structure in Obesity-Related Diabetes Diabetes, August 1, 2005; 54(8): 2436 - 2446. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Swords, S. Aylwin, L. Perry, J. Arola, A. B. Grossman, J. P. Monson, and A. J. L. Clark The Aberrant Expression of the Gastric Inhibitory Polypeptide (GIP) Receptor in Adrenal Hyperplasia: Does Chronic Adrenocorticotropin Exposure Stimulate Up-Regulation of GIP Receptors in Cushing's Disease? J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3009 - 3016. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miki, K. Minami, H. Shinozaki, K. Matsumura, A. Saraya, H. Ikeda, Y. Yamada, J. J. Holst, and S. Seino Distinct Effects of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 on Insulin Secretion and Gut Motility Diabetes, April 1, 2005; 54(4): 1056 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nyberg, M. F. Anderson, B. Meister, A.-M. Alborn, A.-K. Strom, A. Brederlau, A.-C. Illerskog, O. Nilsson, T. J. Kieffer, M. A. Hietala, et al. Glucose-Dependent Insulinotropic Polypeptide Is Expressed in Adult Hippocampus and Induces Progenitor Cell Proliferation J. Neurosci., February 16, 2005; 25(7): 1816 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Holst and C. Orskov The Incretin Approach for Diabetes Treatment: Modulation of Islet Hormone Release by GLP-1 Agonism Diabetes, December 1, 2004; 53(suppl_3): S197 - S204. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. C. Chow, T. W. Moon, R. L. C. Hoo, C.-M. Yeung, M. Muller, P. J. Christos, and S. Mojsov Identification and Characterization of a Glucagon Receptor from the Goldfish Carassius auratus: Implications for the Evolution of the Ligand Specificity of Glucagon Receptors in Vertebrates Endocrinology, July 1, 2004; 145(7): 3273 - 3288. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Ding, Q. Zhong, J. Xu, and C. M. Isales Glucose-dependent insulinotropic peptide: differential effects on hepatic artery vs. portal vein endothelial cells Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E773 - E779. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Ding, Q. Zhong, and C. M. Isales Glucose-dependent insulinotropic peptide stimulates thymidine incorporation in endothelial cells: role of endothelin-1 Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E390 - E396. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker International Union of Pharmacology. XXXV. The Glucagon Receptor Family Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Yeung, S. Mojsov, P.-Y. Mok, and B. K. C. Chow Isolation and Structure-Function Studies of a Glucagon-Like Peptide 1 Receptor from Goldfish Carassius auratus: Identification of Three Charged Residues in Extracellular Domains Critical for Receptor Function Endocrinology, December 1, 2002; 143(12): 4646 - 4654. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ehses, S. L. Pelech, R. A. Pederson, and C. H. S. McIntosh Glucose-dependent Insulinotropic Polypeptide Activates the Raf-Mek1/2-ERK1/2 Module via a Cyclic AMP/cAMP-dependent Protein Kinase/Rap1-mediated Pathway J. Biol. Chem., September 27, 2002; 277(40): 37088 - 37097. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Groussin, K. Perlemoine, V. Contesse, H. Lefebvre, A. Tabarin, P. Thieblot, J. L. Schlienger, J. P. Luton, X. Bertagna, and J. Bertherat The Ectopic Expression of the Gastric Inhibitory Polypeptide Receptor Is Frequent in Adrenocorticotropin-Independent Bilateral Macronodular Adrenal Hyperplasia, but Rare in Unilateral Tumors J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 1980 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kashima, T. Miki, T. Shibasaki, N. Ozaki, M. Miyazaki, H. Yano, and S. Seino Critical Role of cAMP-GEFII{middle dot}Rim2 Complex in Incretin-potentiated Insulin Secretion J. Biol. Chem., November 30, 2001; 276(49): 46046 - 46053. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Trumper, K. Trumper, H. Trusheim, R. Arnold, B. Goke, and D. Horsch Glucose-Dependent Insulinotropic Polypeptide Is a Growth Factor for {beta} (INS-1) Cells by Pleiotropic Signaling Mol. Endocrinol., September 1, 2001; 15(9): 1559 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y.-Y. Chan, R. T.-K. Pang, and B. K.-C. Chow Functional Segregation of the Highly Conserved Basic Motifs within the Third Endoloop of the Human Secretin Receptor Endocrinology, September 1, 2001; 142(9): 3926 - 3934. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Deacon, P. Danielsen, L. Klarskov, M. Olesen, and J. J. Holst Dipeptidyl Peptidase IV Inhibition Reduces the Degradation and Clearance of GIP and Potentiates Its Insulinotropic and Antihyperglycemic Effects in Anesthetized Pigs Diabetes, July 1, 2001; 50(7): 1588 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kindmark, J. Pigon, and S. Efendic Glucose-Dependent Insulinotropic Hormone Potentiates the Hypoglycemic Effect of Glibenclamide in Healthy Volunteers: Evidence for an Effect on Insulin Extraction J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2015 - 2019. [Abstract] [Full Text] |
||||
![]() |
A. Lacroix, N. N'Diaye, J. Tremblay, and P. Hamet Ectopic and Abnormal Hormone Receptors in Adrenal Cushing's Syndrome Endocr. Rev., February 1, 2001; 22(1): 75 - 110. [Abstract] [Full Text] |
||||
![]() |
N. M. Sherwood, S. L. Krueckl, and J. E. McRory The Origin and Function of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)/Glucagon Superfamily Endocr. Rev., December 1, 2000; 21(6): 619 - 670. [Abstract] [Full Text] |
||||
![]() |
R. J. Bollag, Q. Zhong, P. Phillips, L. Min, L. Zhong, R. Cameron, A. L. Mulloy, H. Rasmussen, F. Qin, K. H. Ding, et al. Osteoblast-Derived Cells Express Functional Glucose-Dependent Insulinotropic Peptide Receptors Endocrinology, March 1, 2000; 141(3): 1228 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text] |
||||
![]() |
S. R. J. Hoare, T. I. Bonner, and T. B. Usdin Comparison of Rat and Human Parathyroid Hormone 2 (PTH2) Receptor Activation: PTH Is a Low Potency Partial Agonist at the Rat PTH2 Receptor Endocrinology, October 1, 1999; 140(10): 4419 - 4425. [Abstract] [Full Text] |
||||
![]() |
M. B. Wheeler, R. W. Gelling, S. A. Hinke, B. Tu, R. A. Pederson, F. Lynn, J. Ehses, and C. H. S. McIntosh Characterization of the Carboxyl-terminal Domain of the Rat Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor. A ROLE FOR SERINES 426 AND 427 IN REGULATING THE RATE OF INTERNALIZATION J. Biol. Chem., August 27, 1999; 274(35): 24593 - 24601. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Tseng, X.-Y. Zhang, and M. M. Wolfe Effect of GIP and GLP-1 antagonists on insulin release in the rat Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1049 - E1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Szatmari Evidence-based child psychiatry and the two solitudes Evid. Based Ment. Health, February 1, 1999; 2(1): 6 - 7. [Full Text] |
||||
![]() |
C. Jagger, A. Gallagher, T. Chambers, and M. Pondel The Porcine Calcitonin Receptor Promoter Directs Expression of a Linked Reporter Gene in a Tissue and Developmental Specific Manner in Transgenic Mice Endocrinology, January 1, 1999; 140(1): 492 - 499. [Abstract] [Full Text] |
||||
![]() |
M. C. Lebrethon, O. Avallet, Y. Reznik, F. Archambeaud, J. Combes, T. B. Usdin, G. Narboni, J. Mahoudeau, and J. M. Saez Food-Dependent Cushing's Syndrome: Characterization and Functional Role of Gastric Inhibitory Polypeptide Receptor in the Adrenals of Three Patients J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4514 - 4519. [Abstract] [Full Text] |
||||
![]() |
V. Serre, W. Dolci, E. Schaerer, L. Scrocchi, D. Drucker, S. Efrat, and B. Thorens Exendin-(9-39) Is an Inverse Agonist of the Murine Glucagon-Like Peptide-1 Receptor: Implications for Basal Intracellular Cyclic Adenosine 3',5'-Monophosphate Levels and {beta}-Cell Glucose Competence Endocrinology, November 1, 1998; 139(11): 4448 - 4454. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Brubaker, J. Schloos, and D. J. Drucker Regulation of Glucagon-Like Peptide-1 Synthesis and Secretion in the GLUTag Enteroendocrine Cell Line Endocrinology, October 1, 1998; 139(10): 4108 - 4114. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Chabre, P. Liakos, J. Vivier, P. Chaffanjon, F. Labat-Moleur, M. Martinie, S. P. Bottari, I. Bachelot, E. M. Chambaz, G. Defaye, et al. Cushing's Syndrome due to a Gastric Inhibitory Polypeptide-Dependent Adrenal Adenoma: Insights into Hormonal Control of Adrenocortical Tumorigenesis J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3134 - 3143. [Abstract] [Full Text] |
||||
![]() |
A. Bisello, A. E. Adams, D. F. Mierke, M. Pellegrini, M. Rosenblatt, L. J. Suva, and M. Chorev Parathyroid Hormone-Receptor Interactions Identified Directly by Photocross-linking and Molecular Modeling Studies J. Biol. Chem., August 28, 1998; 273(35): 22498 - 22505. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. NDiaye, J. Tremblay, P. Hamet, W. W. De Herder, and A. Lacroix Adrenocortical Overexpression of Gastric Inhibitory Polypeptide Receptor Underlies Food-Dependent Cushing's Syndrome J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2781 - 2785. [Abstract] [Full Text] |
||||
![]() |
V. I. DeAlmeida and K. E. Mayo Identification of Binding Domains of the Growth Hormone-Releasing Hormone Receptor by Analysis of Mutant and Chimeric Receptor Proteins Mol. Endocrinol., May 1, 1998; 12(5): 750 - 765. [Abstract] [Full Text] |
||||
![]() |
C. G. Unson, C.-R. Wu, C. P. Cheung, and R. B. Merrifield Positively Charged Residues at Positions 12, 17, and 18 of Glucagon Ensure Maximum Biological Potency J. Biol. Chem., April 24, 1998; 273(17): 10308 - 10312. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. G. Lelianova, B. A. Davletov, A. Sterling, M. A. Rahman, E. V. Grishin, N. F. Totty, and Y. A. Ushkaryov alpha -Latrotoxin Receptor, Latrophilin, Is a Novel Member of the Secretin Family of G Protein-coupled Receptors J. Biol. Chem., August 22, 1997; 272(34): 21504 - 21508. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iida-Klein, J. Guo, M. Takemura, M. T. Drake, J. T. Potts Jr., A. Abou-Samra, F. R. Bringhurst, and G. V. Segre Mutations in the Second Cytoplasmic Loop of the Rat Parathyroid Hormone (PTH)/PTH-related Protein Receptor Result in Selective Loss of PTH-stimulated Phospholipase C Activity J. Biol. Chem., March 14, 1997; 272(11): 6882 - 6889. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Azarani, D. Goltzman, and J. Orlowski Structurally Diverse N-terminal Peptides of Parathyroid Hormone (PTH) and PTH-related Peptide (PTHRP) Inhibit the Na+/H+ Exchanger NHE3 Isoform by Binding to the PTH/PTHRP Receptor Type I and Activating Distinct Signaling Pathways J. Biol. Chem., June 21, 1996; 271(25): 14931 - 14936. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gardella, M. D. Luck, M.-H. Fan, and C. Lee Transmembrane Residues of the Parathyroid Hormone (PTH)/PTH-related Peptide Receptor That Specifically Affect Binding and Signaling by Agonist Ligands J. Biol. Chem., May 31, 1996; 271(22): 12820 - 12825. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Thorens, N. Dériaz, D. Bosco, A. DeVos, D. Pipeleers, F. Schuit, P. Meda, and A.ée Porret Protein Kinase A-dependent Phosphorylation of GLUT2 in Pancreatic beta Cells J. Biol. Chem., April 5, 1996; 271(14): 8075 - 8081. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Unson, A. M. Cypess, H. N. Kim, P. K. Goldsmith, C. J. L. Carruthers, R. B. Merrifield, and T. P. Sakmar Characterization of Deletion and Truncation Mutants of the Rat Glucagon Receptor J. Biol. Chem., November 17, 1995; 270(46): 27720 - 27727. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Usdin, C. Gruber, and T. I. Bonner Identification and Functional Expression of a Receptor Selectively Recognizing Parathyroid Hormone, the PTH2 Receptor J. Biol. Chem., June 30, 1995; 270(26): 15455 - 15458. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iida-Klein, J. Guo, L. Y. Xie, H. Jüppner, J. T. Potts Jr., H. M. Kronenberg, F. R. Bringhurst, A. B. Abou-Samra, and G. V. Segre Truncation of the Carboxyl-terminal Region of the Rat Parathyroid Hormone (PTH)/PTH-related Peptide Receptor Enhances PTH Stimulation of Adenylyl Cyclase but Not Phospholipase C J. Biol. Chem., April 14, 1995; 270(15): 8458 - 8465. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ehses, S. S. T. Lee, R. A. Pederson, and C. H. S. McIntosh A New Pathway for Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor Signaling. EVIDENCE FOR THE INVOLVEMENT OF PHOSPHOLIPASE A2 IN GIP-STIMULATED INSULIN SECRETION J. Biol. Chem., June 22, 2001; 276(26): 23667 - 23673. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |